Mr. Segal brings decades of experience advising high-net-worth individuals, family offices, and institutions on long-term investment strategy, capital allocation, and risk management. His background spans public and private markets, with a particular focus on identifying durable growth platforms and emerging technologies with the potential to generate long-term value — a perspective that directly complements DRAI Health's mission to make AI-enabled preventive care and clinical decision support more accessible and efficient.

Mr. Segal has spent his career working closely with entrepreneurs, executives, and institutional investors to navigate complex market environments and long-term strategic decisions. His appointment to the Board enhances DRAI Health's governance infrastructure and strategic oversight as the company advances its AI-powered healthcare platform across direct-to-consumer, enterprise, and institutional healthcare markets, addressing critical inefficiencies in preventive care delivery, diagnostics, and clinical decision support.